The European Union’s review of the Solvency II directive, adopted after years of negotiation, represents the most significant overhaul of Europe’s insurance regulatory framework since its original implementation in 2016. The changes, which are being phased in over 2025-2027, have implications for capital requirements, investment strategy, product design, and competitive dynamics across the European insurance market.
Key Changes
Long-Term Guarantee Measures — The review introduces modifications to the volatility adjustment and matching adjustment mechanisms that allow insurers to reduce the market-consistent valuation of long-duration liabilities. These changes are particularly beneficial for life insurers with significant annuity portfolios, as they reduce artificial balance sheet volatility caused by temporary spread movements.
Interest Rate Risk — The extrapolation methodology for risk-free interest rates has been revised, with a later convergence point to the ultimate forward rate. This change increases the present value of long-duration liabilities, partially offsetting the benefits of the volatility adjustment reforms, and requires life insurers to reassess their asset-liability management strategies.
Proportionality — A new proportionality framework reduces regulatory burden for smaller insurers that meet specified criteria. Simplified reporting requirements, reduced governance demands, and streamlined ORSA processes aim to preserve the risk-based principles of Solvency II while recognising that one-size-fits-all regulation is disproportionate for smaller, less complex entities.
Climate Risk — The review formally integrates climate risk into the Solvency II framework. Insurers are required to conduct climate scenario analysis as part of their ORSA and to consider climate-related factors in investment decisions. While no explicit climate capital charge has been introduced, EIOPA has been mandated to assess whether one should be developed.
Impact on Swiss Insurers
Swiss insurers operating in the EU through branches or subsidiaries are directly affected by the Solvency II review. The Swiss Solvency Test (SST), which predates Solvency II, maintains equivalence recognition but differs in several technical aspects. FINMA has indicated that it will monitor the Solvency II changes and assess whether corresponding modifications to the SST are warranted.
For Swiss reinsurers, the changes to Solvency II capital requirements for cedants may influence reinsurance demand patterns. Modifications to the counterparty default risk module and the treatment of reinsurance recoverables in the standard formula could affect the capital benefit that EU insurers derive from reinsurance purchasing, with potential implications for cession rates and programme structures.
Market Implications
The Solvency II review is expected to release approximately EUR 100 billion in capital across the European insurance industry, primarily benefiting life insurers with long-duration liabilities. This capital release could fund increased shareholder distributions, strategic acquisitions, or expansion into new markets and product lines.
However, the reforms also introduce new requirements that will absorb management attention and compliance resources. The enhanced sustainability reporting requirements, macroprudential tools, and resolution planning mandates represent new obligations that partially offset the capital relief benefits.